Joint (NASDAQ:JYNT) Major Shareholder Charles Jobson Acquires 44,963 Shares of Stock

Joint logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Major shareholder Charles Jobson bought 44,963 shares at an average of $6.65, spending about $299,004. His holdings rose 2.2% to 2,091,430 shares.
  • Joint reported quarterly EPS of $0.10, beating the $0.08 consensus, while revenue of $13.55 million missed the $14.85 million forecast. Shares traded at $6.43, near their 52-week low of $6.42.
  • Analyst sentiment was cautious: the consensus rating was “Reduce,” with a consensus price target of $8.00; B. Riley lowered its target from $9 to $8 and maintained a neutral rating.
  • Five stocks to consider instead of Joint.

The Joint Corp. (NASDAQ:JYNT - Get Free Report) major shareholder Charles Jobson bought 44,963 shares of the business's stock in a transaction on Thursday, November 19th. The stock was purchased at an average price of $6.65 per share, for a total transaction of $299,003.95. Following the completion of the acquisition, the insider owned 2,091,430 shares of the company's stock, valued at approximately $13,908,009.50. This trade represents a 2.20% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.

Joint Price Performance

JYNT stock traded down $0.21 during trading hours on Thursday, reaching $6.43. The stock had a trading volume of 107,906 shares, compared to its average volume of 80,904. The stock has a 50-day simple moving average of $7.41 and a 200 day simple moving average of $8.41. The Joint Corp. has a fifty-two week low of $6.42 and a fifty-two week high of $10.67. The stock has a market capitalization of $88.10 million, a PE ratio of 32.18 and a beta of 1.16.

Joint (NASDAQ:JYNT - Get Free Report) last announced its earnings results on Thursday, November 5th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. The company had revenue of $13.55 million during the quarter, compared to analysts' expectations of $14.85 million. Joint had a net margin of 4.81% and a return on equity of 22.11%. On average, sell-side analysts forecast that The Joint Corp. will post 0.31 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently commented on JYNT shares. B. Riley Financial cut their price objective on shares of Joint from $9.00 to $8.00 and set a "neutral" rating for the company in a report on Monday, November 9th. Wall Street Zen downgraded Joint from a "buy" rating to a "hold" rating in a research report on Saturday, November 14th. Finally, Weiss Ratings raised Joint from a "sell (d)" rating to a "sell (d+)" rating in a research report on Wednesday, November 11th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Joint presently has a consensus rating of "Reduce" and a consensus price target of $8.00.

View Our Latest Analysis on JYNT

Institutional Investors Weigh In On Joint

A number of large investors have recently modified their holdings of JYNT. BlackRock Inc. bought a new stake in Joint in the second quarter worth $2,534,000. Marshall Wace LLP lifted its position in shares of Joint by 372.2% in the third quarter. Marshall Wace LLP now owns 251,089 shares of the company's stock worth $1,858,000 after buying an additional 197,916 shares during the last quarter. Skylands Capital LLC boosted its stake in shares of Joint by 5.6% during the 3rd quarter. Skylands Capital LLC now owns 946,045 shares of the company's stock worth $7,001,000 after acquiring an additional 50,473 shares in the last quarter. Grandeur Peak Global Advisors LLC bought a new stake in shares of Joint during the 2nd quarter worth about $19,059,000. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Joint by 37.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 153,754 shares of the company's stock valued at $1,361,000 after acquiring an additional 41,842 shares during the last quarter. Institutional investors and hedge funds own 76.88% of the company's stock.

About Joint

(Get Free Report)

The Joint Corp. operates and franchises The Joint Chiropractic, a network of clinics providing chiropractic care in the United States. Its clinics offer services such as spinal adjustments and other chiropractic treatments focused on musculoskeletal health and wellness. The company's business model emphasizes convenient access to care, with options that include walk-in visits and recurring membership plans. The Joint Corp. was established in 2010 and is headquartered in Scottsdale, Arizona.

Recommended Stories

Insider Buying and Selling by Quarter for Joint (NASDAQ:JYNT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Joint Right Now?

Before you consider Joint, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.

While Joint currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines